Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease (Molecular Neurobiology, (2018), 55, 1, (201-212), 10.1007/s12035-017-0733-x)
Autor
Requejo C.
Ruiz-Ortega J.A.
Bengoetxea H.
Bulnes S.
Ugedo L.
Lafuente J.V.
Resumen
The authors found a terrible mistake in the manuscript. The legends from the Fig. 5 and 6 are interchanged. The Fig. 5 should be appeared with the legend from the Fig. 6 and Fig. 6 should be appeared with the legend from the Fig. 5. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease (2020)
Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; Bulnes S.; Ugedo L.; Lafuente J.V. (Humana Press Inc., 2018) -
Article
Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease (2020)
Requejo C.; Ruiz-Ortega J.A.; Cepeda H.; Sharma A.; Sharma H.S.; Ozkizilcik A.; Tian R.; Moessler H.; Ugedo L.; Lafuente J.V. (Humana Press Inc., 2018) -
Article
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors (2020)
Requejo C.; Ruiz-Ortega J.A.; Bengoetxea H.; García-Blanco A.; Herrán E.; Aristieta A.; Igartua M.; Pedraz J.L.; Ugedo L.; Hernández R.M.; ... (Humana Press Inc., 2017)